Names and Identifiers

• • Cefpiramide
  • Cefpiramide acid
  • 7-[2-[(4-hydroxy-6-methylpyridine-3-carbonyl)-amino]-2-(4-hydroxy phenyl)-acetylamin]-3-(1-methyl-1H-tetrazole-5-thiomethyl)-8-keto-5-thiox-1-azole[4.2.0]octadiene-2-carboxylic acid
  • HMS3715H12
  • CEFPIRAMIDE [MI]
  • Cefpiramide acid;Cefpiramido;Cefpiramidum;WY-44635;SM-1652
  • CEFPIRAMIDE [MART.]
  • DB00430
  • DTXCID4026630
  • NCGC00167444-01
  • (7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • GTPL12027
  • CEFPIRAMIDE [USP IMPURITY]
  • Cefpiramidum
  • Cefpiramido [INN-Spanish]
  • WY-44635
  • CEFPIRAMIDE [USP-RS]
  • Q4921174
  • (6R,7R)-7-((R)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • WY 44,635
  • CS-0013097
  • SM-1652
  • CHEMBL1201204
  • 70797-11-4
  • AKOS025311237
  • CAS-70797-11-4
  • (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • Cefpiramidum [INN-Latin]
  • NSC 759869
  • NSC-759869
  • CHEBI:59213
  • CEFPIRAMIDE [USAN]
  • s5186
  • WY-44,635
  • UNII-P936YA152N
  • MFCD00864893
  • NCGC00167444-04
  • (6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • NS00011570
  • BRD-K92872987-001-02-9
  • (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • EN300-19766072
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
  • Cefpiramido
  • CEFPIRAMIDE [INN]
  • WY 44635
  • CCG-221235
  • DTXSID6046630
  • SCHEMBL49253
  • (7R)-7-((R)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 7beta-[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
  • CEFPIRAMIDE [WHO-DD]
  • P936YA152N
  • D03428
  • Cefpiramide (USP/INN)
  • HY-B1354
  • Cefpiramide [USAN:USP:INN]
  • (6R,7R)-7-[(2R)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Tox21_112448
  • AS-14170
  • (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • SM 1652
  • BRD-K92872987-001-01-1
  • BRD-K92872987-236-03-9
  • +expand
• • MDL： MFCD00864893
  • Inchi： 1S/C25H24N8O7S2/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40)/t17-,18-,23-/m1/s1
  • InChI Key： PWAUCHMQEXVFJR-PMAPCBKXSA-N
  • SMILES： S1CC(CSC2=NN=NN2C)=C(C(=O)O)N2C([C@H]([C@@H]12)NC([C@@H](C1C=CC(=CC=1)O)NC(C1=CNC(C)=CC1=O)=O)=O)=O

Computed Properties

Experimental Properties